Prescribing information

 

Prescribing information

Explore our webinars from expert dermatology speakers.

If you or your colleagues weren’t able to join our webinars, recordings can be found below. We’ll continue to grow the collection, so keep checking back!

 

 

Click here for Cosentyx®(secukinumab) prescribing information

 

Dermatology 2020: A virtual reality

In our Autumn virtual meeting series, we had a number of key opinion leaders gather to discuss hot topics in dermatology, including  the latest data in psoriasis. Watch the video above to hear from Dr Amy Foulkes on why you should watch more.

Click to watch the highlights from the series

 

 

 

Click here for Cosentyx®(secukinumab) prescribing information

Webinar highlights: Dermatology clinics in a virtual era

The COVID-19 pandemic has transformed dermatology services – but where do we go from here? In this webinar highlights video, Dr Laura Savage explores how we can embrace technology to continue making positive changes for our patients.

“Many patients can be managed less frequently, they can be managed remotely or they can be managed with advice and guidance from the GP. That’s only going to continue to improve our capacity and reduces patient inconvenience.”

Register to watch the full video

 

 

Click here for Cosentyx®(secukinumab) prescribing information

Webinar highlights: Real-world evidence in clinical decision making

What really matters when making clinical decisions in psoriasis? In the highlights of her webinar, hear Dr Laura Savage discuss how real-world evidence can be used in clinical practice and how it could help inform treatment choices.

“…real-world evidence really is the missing piece of this jigsaw where we really want to try to use that to get an understanding of what’s going to happen in the clinical setting.”
 

Register to watch the full video

 
UK | January 2021 | 100660
×

Ask Speakers

×

Medical Information Request

Adverse events should be reported. Reporting forms and information can be found at yellowcard.mhra.gov.uk. Adverse events should also be reported to Novartis via [email protected] or online through the pharmacovigilance intake (PVI) tool at http://www.report.novartis.com/
If you have a question about the product, please contact Medical Information on 01276 698370 or by email at [email protected]